| Sign In to gain access to subscriptions and/or personal tools. |
Neonatal Mydriasis: Intravenous Lidocaine Adverse ReactionNeuro-Pediatric Unit, itberg{at}szmc.org.il
Neuro-Pediatric Unit
Infectious Disease Unit
Department of Ophthalmology
Department of Neonatology Shaare Zedek Medical Center Jerusalem, Israel Lidocaine (a sodium channel blocker) serves as an antiepilepsy drug in neonates. We present a neonate with a seizure disorder who acutely developed pupillary mydriasis secondary to lidocaine overdose. We suggest adding this side effect to the list of untoward effects of lidocaine and to the differential diagnosis of fixed dilated pupils in neonates treated with lidocaine. (J Child Neurol 2002; 17:400-401).
Journal of Child Neurology, Vol. 17, No. 5,
400-401 (2002) This article has been cited by other articles:
|
|
||||||||||||||


